Overview
Stephen C. Mathai, MD, MHS is an Associate Professor of Medicine and part of the Johns Hopkins Pulmonary Hypertension Program. Dr. Mathai received his undergraduate degree from Rutgers College and medical degree from Jefferson Medical College. He pursued residency training in Internal Medicine at Thomas Jefferson University Hospital, where he also served as Chief Medical Resident. Dr. Mathai came to Johns Hopkins for fellowship training in Pulmonary and Critical Care Medicine. During his 5-year fellowship, he obtained a Masters of Health Science degree from the Johns Hopkins Bloomberg School of Public Health and successfully competed for an individual Ruth L. Kirschstein National Research Service Award. Subsequently, he received a K23 award for his research in pulmonary vascular disease in scleroderma. He currently serves as Co-Principal Investigator for the Johns Hopkins PVDOMICS program supported by the NIH and is principal investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is also the Co-Director of the Ann Dana Kusch Multidisciplinary Program for Interstitial Lung Disease and Pulmonary Hypertension. Dr. Mathai has been active in numerous committees and holds several leadership positions in academic societies. He is the current chair of the Pulmonary Vascular Disease Network for the American College of Chest Physicians and has served on the steering committee for this organization for the past 4 years. He has served on several committees for the Pulmonary Circulation Assembly of the American Thoracic Society, including the Program Committee and Nominations Committee. He has organized symposia and delivered presentations related to pulmonary hypertension at numerous international meetings. He is the author of more than 100 publications and has given invited research lectures nationally and internationally. Dr. Mathai is also an active member of patient advocacy organizations. Currently, he is a member of the Scientific Leadership Council of the Pulmonary Hypertension Association where he serves as national chairperson of the Preceptorship Program Planning Committee. He is also a member of the Rare Disease Advisory Panel for the Patient Centered Outcomes Research Institute. Dr. Mathai also serves as the faculty leader of the inpatient pulmonary service, the Carol Johns Service, where he is responsible for the education of the internal medicine housestaff and pulmonary fellows. He has also received the Frederick L. Brancati Award for mentorship from the Department of Medicine at Johns Hopkins.
Dr. Mathai is rated as an Experienced provider by MediFind in the treatment of Cystic Fibrosis. His top areas of expertise are Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Sarcoidosis, and Lung Transplant.
His clinical research consists of co-authoring 208 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
601 North Caroline Street, Floor 7, Floor 7, Baltimore, MD 21287
Additional Areas of Focus
Dr. Mathai has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Johns Hopkins Outpatient Center
Dr. Lechtzin is a pulmonary and critical care medicine physician. He directs the Adult CF program and the neuromuscular pulmonary clinic at Johns Hopkins and is an expert in the treatment of cystic fibrosis, pulmonary complications of neuromuscular disease and the care of critically ill patients in the Medical ICU. He is a member of the Longcope Firm Faculty and provides teaching to medical students and residents at Johns Hopkins. Dr. Lechtzin is rated as a Distinguished provider by MediFind in the treatment of Cystic Fibrosis. His top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, Lung Transplant, and Endoscopy.
Johns Hopkins Outpatient Center
Dr. Natalie West is a pulmonary specialist in the Greater Baltimore area who specializes in the diagnosis and treatment of cystic fibrosis. Her focus also includes the treatment of interstitial lung disease, lung transplantation, COPD, asthma, and pulmonary hypertension. She also manages patients in the medical intensive care unit with acute respiratory failure caused by asthma, pneumonia, COPD, and the acute respiratory distress syndrome, as well as other conditions such as gastrointestinal bleeding, pulmonary embolism, diabetic ketoacidosis, and shock from sepsis, hypovolemia, and heart disease. Dr. West also serves as the associate program director of the Johns Hopkins Pulmonary and Critical Care Fellowship Program and plays an active role in recruitment of new fellows and mentoring fellows in the division. Dr. West is rated as a Distinguished provider by MediFind in the treatment of Cystic Fibrosis. Her top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, Pseudomonas Stutzeri Infections, and Lung Transplant.
Privia Medical Group, LLC
Mark Jennings is a Pulmonary Medicine specialist and a Pediatrics provider in Lanham, Maryland. Dr. Jennings is rated as a Distinguished provider by MediFind in the treatment of Cystic Fibrosis. His top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, and Jaundice. Dr. Jennings is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Pulmonary HypertensionDr. Mathai isElite. Learn about Pulmonary Hypertension.
- Distinguished
- Pulmonary Veno-Occlusive DiseaseDr. Mathai isDistinguished. Learn about Pulmonary Veno-Occlusive Disease.
- Systemic Sclerosis (SSc)Dr. Mathai isDistinguished. Learn about Systemic Sclerosis (SSc).
- Advanced
- Acute Interstitial PneumoniaDr. Mathai isAdvanced. Learn about Acute Interstitial Pneumonia.
- Cerebral HypoxiaDr. Mathai isAdvanced. Learn about Cerebral Hypoxia.
- Heart Failure with Preserved Ejection Fraction (HFpEF)
- Interstitial Lung DiseaseDr. Mathai isAdvanced. Learn about Interstitial Lung Disease.
- Lung TransplantDr. Mathai isAdvanced. Learn about Lung Transplant.
- SarcoidosisDr. Mathai isAdvanced. Learn about Sarcoidosis.
- Experienced
- Acute Respiratory Distress Syndrome (ARDS)
- Chronic Obstructive Pulmonary Disease (COPD)
- COVID-19Dr. Mathai isExperienced. Learn about COVID-19.
- Cystic FibrosisDr. Mathai isExperienced. Learn about Cystic Fibrosis.
- EmphysemaDr. Mathai isExperienced. Learn about Emphysema.
- Hypersensitivity PneumonitisDr. Mathai isExperienced. Learn about Hypersensitivity Pneumonitis.